Sponsor

California Institute for Regenerative Medicine (CIRM)

Clinical research sponsor

Published trials14
Recruiting shown1
Roles1
SourceClinicalTrials.gov

Clinical trials

14 shown
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsNCT04119024 · collaborator · 2025-10-07
RECRUITING
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's DiseaseNCT07106021 · collaborator · 2025-07-17
ACTIVE_NOT_RECRUITING
Phase 1/2a Study of ANPD001 in Parkinson DiseaseNCT06344026 · collaborator · 2024-01-23
ENROLLING_BY_INVITATION
GDNF Gene Therapy for Parkinson's DiseaseNCT04167540 · collaborator · 2020-04-01
ACTIVE_NOT_RECRUITING
CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung CancerNCT03546361 · collaborator · 2019-07-08
ACTIVE_NOT_RECRUITING
Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 DiabetesNCT03977662 · collaborator · 2019-07-01
COMPLETED
HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal MetastasesNCT03696030 · collaborator · 2018-11-27
ACTIVE_NOT_RECRUITING
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApyNCT03145298 · collaborator · 2017-10-01
COMPLETED
A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia UnawarenessNCT03163511 · collaborator · 2017-07-06
COMPLETED
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantNCT02797470 · collaborator · 2016-06-23
ACTIVE_NOT_RECRUITING
Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected PatientsNCT02500849 · collaborator · 2016-03-10
ACTIVE_NOT_RECRUITING
Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)NCT02691247 · collaborator · 2016-02-01
COMPLETED
A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes MellitusNCT02239354 · collaborator · 2014-09-01
TERMINATED
Allogeneic Heart Stem Cells to Achieve Myocardial RegenerationNCT01458405 · collaborator · 2012-11-13
TERMINATED

Sponsor roles

collaborator14

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.